Saying goodbye to a grueling year, BioCentury editors have furrowed among the disasters to pick out some of the positives from 2020, and call out some of the worst of the pandemic’s collateral damage....
...vaccine in the world with Moderna and with Pfizer. We will cater to the highest medical need... ...according to their principles. They do 5%, 10%, 20%, they also look at the highest medical need... ...see now in Europe, we see it in the U.S., you start with the highest medical need...
In recent years, it has become fashionable to focus on the high price of new treatments for certain cancers and rare diseases. Many observers ask why it is that U.S. citizens should subsidize the rest...
The extraordinary collaboration and commitment on the part of biopharma companies and governments that COVID-19 has inspired should serve as models for addressing unmet medical needs after the crisis has passed, Margaret Hamburg, who served...
Saying goodbye to a grueling year, BioCentury editors have furrowed among the disasters to pick out some of the positives from 2020, and call out some of the worst of the pandemic’s collateral damage....
...vaccine in the world with Moderna and with Pfizer. We will cater to the highest medical need... ...according to their principles. They do 5%, 10%, 20%, they also look at the highest medical need... ...see now in Europe, we see it in the U.S., you start with the highest medical need...
In recent years, it has become fashionable to focus on the high price of new treatments for certain cancers and rare diseases. Many observers ask why it is that U.S. citizens should subsidize the rest...
The extraordinary collaboration and commitment on the part of biopharma companies and governments that COVID-19 has inspired should serve as models for addressing unmet medical needs after the crisis has passed, Margaret Hamburg, who served...